LH 徠博科

添加自選

200.590
+0.340+0.17%

交易中 05/03 11:50 (美東)

169.08億總市值39.56市盈率TTM

關於徠博科公司

徠博科公司是一家生命科學公司，致力於提供重要信息，幫助衛生專業人員做出明確而自信的決定。它通過藥物開發和診斷部門運作。藥物開發部門包括先導優化、臨牀前安全性評估、分析服務、臨牀試驗、中心實驗室、生物標誌物和伴隨診斷、市場準入和技術解決方案。診斷部門包括初級保健、婦女健康、專科醫學、腫瘤學、ACOs以及醫院和衛生系統。

公司介紹

公司代碼LH

公司名稱徠博科

上市日期1991/04/24

成立日期1971

CEOMr. Adam H. Schechter

所屬市場紐交所

員工數量67000

證券類型海外普通股

年結日12-31

公司地址358 South Main Street

城市Burlington

省份北卡羅來納州

國家美國

郵編27215-5837

電話1-336-229-1127

網址http://www.labcorp.com

董事高管

姓名
職務
年薪

Adam H. Schechter
Chairman of the Board, President and Chief Executive Officer
1597.94萬

Lance V. Berberian
Executive Vice President and Chief Information and Technology Officer
--

Sandra D. van der Vaart
Executive Vice President, Chief Legal Officer, Chief Compliance Officer and Corporate Secretary
--

Anita Graham
Executive Vice President and Chief Human Resources Officer
255.60萬

Megan D. Bailey
Executive Vice President, Chief Strategy and Transformation Officer
--

Mark Schroeder
Executive Vice President, President, Diagnostics and Chief Operations Officer
379.51萬

Glenn A. Eisenberg
Executive Vice President and Chief Financial Officer
495.68萬

Peter J. Wilkinson
Senior Vice President and Chief Accounting Officer
--

Brian J. Caveney, J.D.,M.D.,M.P.H.
Executive Vice President, President, Early Development Research Laboratories and Chief Medical and Scientific Officer
347.64萬